p53 Immunohistochemistry Predicts 17p13(TP53) Deletion in CLL

被引：0
|
作者：
Jiang, A.
Qi, C.
Chang, H.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1223
引用
收藏
页码：269A / 269A
页数：1
相关论文
共 50 条
  • [1] p53 Immunohistochemistry Predicts 17p13(TP53) Deletion in CLL
    Jiang, A.
    Qi, C.
    Chang, H.
    LABORATORY INVESTIGATION, 2009, 89 : 269A - 269A
  • [2] 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
    M K Dijkstra
    K van Lom
    D Tielemans
    F Elstrodt
    A W Langerak
    M B van ‘t Veer
    M Jongen-Lavrencic
    Leukemia, 2009, 23 : 625 - 627
  • [3] 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
    Dijkstra, M. K.
    van Lom, K.
    Tielemans, D.
    Elstrodt, F.
    Langerak, A. W.
    van't Veer, M. B.
    Jongen-Lavrencic, M.
    LEUKEMIA, 2009, 23 (03) : 625 - 627
  • [4] TP53 Protein Expression, But Not 17p13 Deletion, is Useful in Rapid Screening and Triage of TP53 Mutation in Acute Myeloid Leukemia
    Nwaoduah, Nneamaka
    Bernabeu, Belen Quereda
    Wang, Zixuan
    Liu, Jinglan
    Uppal, Guldeep
    Peiper, Stephen
    Gong, Jerald
    LABORATORY INVESTIGATION, 2018, 98 : 541 - 541
  • [5] TP53 Protein Expression, But Not 17p13 Deletion, is Useful in Rapid Screening and Triage of TP53 Mutation in Acute Myeloid Leukemia
    Nwaoduah, Nneamaka
    Bernabeu, Belen Quereda
    Wang, Zixuan
    Liu, Jinglan
    Uppal, Guldeep
    Peiper, Stephen
    Gong, Jerald
    MODERN PATHOLOGY, 2018, 31 : 541 - 541
  • [6] Aberrant Nuclear p53 Expression Predicts Hemizygous 17p (TP53) Deletion in Chronic Lymphocytic Leukemia
    Chang, Hong
    Jiang, Allan M.
    Qi, Connie X. Y.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) : 70 - 74
  • [7] Genetic aberrations in a prospective randomized B-CLL trial:: Deletion 17p13 (p53) predicts for nonresponse to fludarabine.
    Stilgenbauer, S
    Rummel, M
    Bullinger, L
    Kröber, A
    Lichter, P
    Bergmann, L
    Döhner, H
    BLOOD, 2000, 96 (11) : 515A - 515A
  • [8] P53 inactivation in CLL: Pattern of 110 TP53 mutations
    Zenz, Thorsten
    Trbusek, Martin
    Smardova, Jana
    Haebe, Sonja
    Denzel, Tina
    Malcikova, Jitka
    Doubek, Michael
    Schwarz, Jiri
    Dohner, Hartmin
    Stilgenbauer, Stephan
    BLOOD, 2007, 110 (11) : 615A - 615A
  • [9] Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas
    Clausen, OPF
    Lothe, RA
    Borresen-Dale, AL
    De Angelis, P
    Chen, Y
    Rognum, TO
    Meling, GI
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (04) : 215 - 223
  • [10] 17p Deletion in CLL: Detailed Analysis of TP53 Mutations, Alternative Mechanisms of p53 Inactivation, Clone Size and Clonal Evolution
    Zenz, Thorsten
    Sarno, Antonio
    Haebe, Sonja
    Denzel, Tina
    Mohr, Julia
    Vollmer, Dominik
    Heuberger, Maria
    Winkler, Dirk
    Kienle, Dirk
    Buehler, Andreas
    Truong, Sim
    Patten, Nancy
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD, 2008, 112 (11) : 291 - 291
12345